Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Covington
Chubb
Boehringer Ingelheim
Healthtrust
Merck

Generated: September 23, 2019

DrugPatentWatch Database Preview

CYPROHEPTADINE HYDROCHLORIDE Drug Profile

  Try a free trial


See Plans and Pricing

« Back to Dashboard

When do Cyproheptadine Hydrochloride patents expire, and what generic alternatives are available?

Cyproheptadine Hydrochloride is a drug marketed by Actavis Mid Atlantic, Halsey, Invatech Pharma, Lannett Co Inc, Lyne, Morton Grove, Naska, Pharm Assoc, Quagen, Torrent, Am Therap, Apex Pharms Inc, Apnar Pharma Lp, Ascot, Beximco Pharms Usa, Boscogen, Chartwell Rx, Duramed Pharms Barr, Fosun Pharma, Heritage Pharma, Kv Pharm, Md Pharm, Mountain, Mylan, Novast Labs, Par Pharm, Pioneer Pharms, Pliva, Strides Pharma, Superpharm, Twi Pharms, Vitarine, Watson Labs, and Zydus Pharms. and is included in thirty-seven NDAs.

The generic ingredient in CYPROHEPTADINE HYDROCHLORIDE is cyproheptadine hydrochloride. There are six drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the cyproheptadine hydrochloride profile page.

Drug patent expirations by year for CYPROHEPTADINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for CYPROHEPTADINE HYDROCHLORIDE
Synonyms for CYPROHEPTADINE HYDROCHLORIDE
0S9323MCT0
1-Methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene) piperidinehydrochloride
1-Methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine hydrochloride
1-Methyl-4-(5-dibenzo[a,e]cycloheptatrienylidene)piperidine hydrochloride
1-methyl-4-{tricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,9,12,14-heptaen-2-ylidene}piperidine hydrochloride
4-(5-Dibenzo(a,e)cycloheptatrienylidene)piperidine hydrochloride
4-(5-Dibenzo[a,e]cycloheptatrienylidene)piperidine hydrochloride
4-(5h-dibenzo [a,d]cyclohepten-5-ylidene)-1-methylpiperidine hydrochloride
4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidine hydrochloride
4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-methylpiperidine hydrochloride
4-(5H-Dibenzo[a,d]cyclohepten-5-ylidine)-methylpiperidine hydrochloride
4-(dibenzo[2,1-b:1',2'-e][7]annulen-11-ylidene)-1-methylpiperidine;hydrochloride
41354-29-4
6032-06-0
969-33-5
969-33-5(anhydrous)
AB0015125
AB2000448
AC-15790
AC1L22FV
AC1Q38XK
AC1Q3BNN
AI3-26940
AKOS015905305
AN-48180
Anarexol
anhydrous cyproheptadine hydrochloride
Antegan
AS-14697
BG0159
C 6022
C21H21N.HCl
CCG-101144
CHEBI:59695
CHEMBL1716
Cipractin
component of Dronactin
Contrallerg
CPD000058431
CS-2423
CTK8F8876
Cycloheptadine hydrochloride
Cypoheptadine hydrochloride
Cyproheptadiene hydrochloride
Cyproheptadine (hydrochloride)
Cyproheptadine chlorhydrate
Cyproheptadine Hcl
cyproheptadine hydrochloride (anh.)
Cyproheptadine Hydrochloride (anhydrous)
Cyproheptadine hydrochloride (Periactin)
Cyproheptadine hydrochloride anhydrous
Cyproheptadine hydrochloride sesquihydrate
Cyproheptadine-hydrochloride
Cyproheptadine(hydrochloride)
Cyproptadine Hydrochloride,(S)
DTXSID5042586
EINECS 213-535-1
EU-0100246
FT-0603147
HMS1568E08
HY-B0366A
Istam
J10393
KS-00001F75
Kulinet
Kyliver
LP00246
LS-114934
M230
MLS000028462
MLS001077277
MLS001424281
MLS002222173
MolPort-003-940-781
NC00394
NCGC00093708-01
NCGC00093708-02
NCGC00260931-01
NSC 169911
NSC-169911
NSC-759282
NSC169911
NSC759282
Nuran
Opera_ID_383
Periactin hydrochloride
Periactin syrup
Periactinol (VAN)
Periactinol hydrochloride
Peritol
Pharmakon1600-01505973
Piperidine, 4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-methyl-, hydrochloride
Piperidine,d]cyclohepten-5-ylidene)-1-methyl-, hydrochloride
Prestwick_139
REGID_for_CID_13770
s2044
SAM001246883
SC-94573
SCHEMBL41842
Sialotin
SMR000058431
SR-01000003077
SR-01000003077-2
SR-01000003077-4
SR-01000003077-9
SW196450-4
Tox21_500246
UNII-0S9323MCT0
Vinorex
VUFB3511
W-106308
WLN: L C676 BYJ BU- DT6N DYTJ A1 &GH
ZPMVNZLARAEGHB-UHFFFAOYSA-N

US Patents and Regulatory Information for CYPROHEPTADINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Twi Pharms CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 206553-001 Nov 29, 2016 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pioneer Pharms CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 087839-001 Feb 8, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Vitarine CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 087284-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pliva CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 088205-001 Jul 26, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Actavis Mid Atlantic CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride SYRUP;ORAL 086833-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Duramed Pharms Barr CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 088232-001 Oct 25, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mountain CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 040537-001 Sep 30, 2003 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Accenture
Baxter
Queensland Health
Chinese Patent Office
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.